Does the inclusion of MRI brain as part of the lung cancer staging pathway identify patients with asymptomatic brain metastases: avoiding inappropriate radical treatment?

被引：0
|
作者：
Eruchie, D. [1 ]
Ewence, A. [1 ]
Higton, A. [1 ]
Macintyre, J. [1 ]
Illsley, M. [1 ]
Hughes, N. [1 ]
机构：
[1] Frimley Pk Hosp NHS Trust, Frimley, Surrey, England
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70057-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non-small-cell lung cancer patients
    Li, Zhenye
    Zhang, Xiangheng
    Jiang, Xiaobing
    Guo, Chengcheng
    Sai, Ke
    Yang, Qunying
    He, Zhenqiang
    Wang, Yang
    Chen, Zhongping
    Li, Wei
    Mou, Yonggao
    ONCOTARGETS AND THERAPY, 2015, 8 : 855 - 860
  • [32] Stereotactic radiosurgery (SRS) for the treatment of brain metastases: Outcomes for lung cancer patients in South Wales
    Walters, Sarah
    Poon-King, Ashley
    Case, Amy
    Maclean, Jillian
    Powell, James
    Iqbal, Najmus Sahar
    LUNG CANCER, 2024, 190
  • [33] Treatment results for non-small cell lung cancer patients presenting with brain metastases
    Shapiro, A.
    Gay, H. A.
    Hahn, S. S.
    Bogart, J. A.
    Shah, H.
    Chung, C. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S512 - S513
  • [34] Disease presentation and treatment outcome in very young patients with brain metastases from lung cancer
    Nieder, Carsten
    Thamm, Reinhard
    Astner, Sabrina T.
    Molls, Michael
    ONKOLOGIE, 2008, 31 (06): : 305 - 308
  • [35] The Impact of Brain Metastases and Their Treatment on Health Utility Scores in Molecular Subsets of Lung Cancer Patients
    O'Kane, Grainne
    Labbe, Catherine
    Su, Susie
    Tse, Brandon
    Tam, Vivian
    Tse, Tiffany
    Doherty, Mark
    Stewart, Erin
    Brown, Catherine
    Cosio, Andrea Perez
    Patel, Devalben
    Liang, Mindy
    Gill, Gurshuran
    Rett, Alexandra
    Leung, Yvonne
    Naik, Hilten
    Eng, Lawson
    Mittmann, Nicole
    Leighl, Natasha
    Feld, Ronald
    Bradbury, Penelope
    Shepherd, Frances
    Xu, Wei
    Howell, Doris
    Liu, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S937 - S937
  • [36] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Mustafa S. Ascha
    Jacqueline Fang Wang
    Priya Kumthekar
    Andrew E. Sloan
    Carol Kruchko
    Jill S. Barnholtz-Sloan
    Scientific Reports, 9
  • [37] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Ascha, Mustafa S.
    Wang, Jacqueline Fang
    Kumthekar, Priya
    Sloan, Andrew E.
    Kruchko, Carol
    Barnholtz-Sloan, Jill S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer
    Doherty, Mark K.
    Korpanty, Grzegorz J.
    Tomasini, Pascale
    Alizadeh, Moein
    Jao, Kevin
    Labbe, Catherine
    Mascaux, Celine M.
    Martin, Petra
    Kamel-Reid, Suzanne
    Tsao, Ming-Sound
    Pintilie, Melania
    Liu, Geoffrey
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Chung, Caroline
    Shepherd, Frances A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (02) : 195 - 202
  • [39] Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases
    Liao, Chien-Yi
    Lee, Cheng-Chia
    Yang, Huai-Che
    Chen, Ching-Jen
    Chung, Wen-Yuh
    Wu, Hsiu-Mei
    Guo, Wan-Yuo
    Liu, Ren-Shyan
    Lu, Chia-Feng
    CANCERS, 2021, 13 (16)
  • [40] Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
    He, Yayi
    Sun, Wenwen
    Wang, Yan
    Ren, Shengxiang
    Li, Xuefei
    Li, Jiayu
    Rivard, Christopher J.
    Zhou, Caicun
    Hirsch, Fred R.
    ONCOTARGETS AND THERAPY, 2016, 9 : 2409 - 2414
12345